Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin E and omega-3 fatty acids to prevent oxidative stress damage in schizophrenia
2009-018054-33Phase 4Completed
- Sponsor
- University of Ljubljana
- Start
- Apr 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vitamin e and omega-3 fatty acid in schizophrenia (4 arms), sponsored by University of Ljubljana. Primary endpoints: PANSS, BARS and 3 more. Started Apr 2010; status: completed.
02
Drugs
vitamin eomega-3 fatty acid
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2009-018054-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018054-33.